MagicTouch SCB is Concept Medical’s sirolimus-coated balloon platform, developed with proprietary Nanoluté technology to deliver sub-micron particles of sirolimus in a biocompatible carrier for deep arterial wall penetration. The device has received CE Mark approval in Europe and a Breakthrough Device designation from the U.S. FDA for small coronary vessels and in-stent restenosis.
Concept Medical Inc., headquartered in Tampa, Florida, is a global leader in cutting-edge drug-delivery technologies for cardiovascular interventions. The company is dedicated to improving patient care through research and development of novel drug-delivery platforms engineered to precisely deliver therapeutic agents to diseased vascular tissue. Concept Medical’s MagicTouch family of sirolimus-coated balloons is the world’s first and most widely used SCB technology, recognized for its versatility, safety and efficacy in treating coronary and peripheral artery disease. The revolutionary MagicTouch and Abluminus product lines have treated over one million patients worldwide, setting a new benchmark in vascular therapy.
For media inquiries, please contact: pr@conceptmedical.com
-
Urvashi questions Shah Rukh Khan’s National Award win, demands clarity on jury’s criteria, says ‘on what…’
-
Meet actress who failed in films but became popular on TV, now the highest-paid star on Indian Television, her name is…
-
This 2-hour 20-minute drama-thriller will leave you speechless, is trending on OTT, has bone-chilling climax, with 8.9 rating of IMDb, movie name is…
-
How much salary Apple pays its employees working in various roles like AI, software development, machine learning, and others?
-
Mindspace Business Parks REIT leases 1.7 million sq ft in Q1, NOI up 24%
